These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36604482)

  • 1. Trend of anticoagulant therapy in elderly patients with atrial fibrillation considering risks of cerebral infarction and bleeding.
    Tsuji N; Takahashi Y; Sakai M; Ohtera S; Kaneyama J; Cho K; Kato G; Ohtsuru S; Nakayama T
    Sci Rep; 2023 Jan; 13(1):192. PubMed ID: 36604482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in oral anticoagulant prescriptions between specialists and non-specialists in patients with cardioembolic stroke caused by non-valvular atrial fibrillation.
    Deguchi I; Osada T; Arai N; Takahashi S
    Heart Vessels; 2022 May; 37(5):867-874. PubMed ID: 34797401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate direct oral anticoagulant prescriptions in patients with non-valvular atrial fibrillation: cross-sectional analysis of the French CACAO cohort study in primary care.
    Ferrat E; Fabre J; Galletout P; Boutin E; Le Breton J; Renard V; Frappé P; Bastuji-Garin S
    Br J Gen Pract; 2021; 71(703):e134-e139. PubMed ID: 33495204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians' Decision and CHA2DS2-VASc and HAS-BLED Scores.
    Balaghi-Inalou M; Parsa SA; Gachkar L; Andalib S
    High Blood Press Cardiovasc Prev; 2018 Mar; 25(1):61-64. PubMed ID: 29076078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation.
    Atwater BD; Guo JD; Keshishian A; Delinger R; Russ C; Rosenblatt L; Jiang J; Yuce H; Ferri M
    J Thromb Thrombolysis; 2024 Jan; 57(1):1-10. PubMed ID: 37530955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
    Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R
    Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis.
    Wu J; Alsaeed ES; Barrett J; Hall M; Cowan C; Gale CP
    Europace; 2020 Sep; 22(9):1311-1319. PubMed ID: 32778878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of frequency of silent cerebral infarction as assessed by serum neuron specific enolase in patients with non-valvular atrial fibrillation:
    Goksuluk H; Ozyuncu N; Duzen IV; Vurgun VK; Tan TS; Gulec S
    Acta Cardiol; 2023 May; 78(3):320-326. PubMed ID: 35469540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolism and bleeding in patients with atrial fibrillation and liver disease - A nationwide register-based cohort study: Thromboembolism and bleeding in liver disease.
    Steensig K; Pareek M; Krarup AL; Sogaard P; Maeng M; Tayal B; Lee CJ; Torp-Pedersen C; Lip GY; Holland-Fischer P; Kragholm KH
    Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101952. PubMed ID: 35609823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of Antithrombotic Treatment for Atrial Fibrillation in Octogenarians: Results of the OCTOFA Study.
    Blacher J; Sorbets E; Guedj Meynier D; Huberman JP; Gauthier J; Cohen S; Hoffman O
    Clin Drug Investig; 2019 Sep; 39(9):891-898. PubMed ID: 31183629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin-naïve or warfarin-experienced patients.
    Perino AC; Fan J; Pundi K; Schmitt S; Kothari M; Din N; Heidenreich PA; Turakhia MP
    Clin Cardiol; 2022 Sep; 45(9):960-969. PubMed ID: 35946047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct oral anticoagulants versus warfarin for secondary prevention of cerebral infarction and bleeding in older adults with atrial fibrillation.
    Kumazawa R; Jo T; Matsui H; Fushimi K; Yasunaga H
    J Am Geriatr Soc; 2022 Jul; 70(7):2029-2039. PubMed ID: 35397114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation.
    Fox KAA; Virdone S; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Kayani G; Oto A; Misselwitz F; Piccini JP; Dalgaard F; Turpie AGG; Verheugt FWA; Kakkar AK;
    Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):214-227. PubMed ID: 33892489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhythm versus rate control strategies regarding anticoagulant use in elderly non-valvular atrial fibrillation patients: Subanalysis of the ANAFIE (All Nippon AF In the Elderly) Registry.
    Yuzawa H; Inoue H; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Ikeda T
    J Cardiol; 2020 Jul; 76(1):87-93. PubMed ID: 32081607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Background characteristics and anticoagulant usage patterns of elderly non-valvular atrial fibrillation patients in the ANAFIE registry: a prospective, multicentre, observational cohort study in Japan.
    Yasaka M; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Okumura K; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Inoue H
    BMJ Open; 2021 Mar; 11(3):e044501. PubMed ID: 34006033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.